TW200507841A - Antibacterial agents - Google Patents
Antibacterial agentsInfo
- Publication number
- TW200507841A TW200507841A TW093108034A TW93108034A TW200507841A TW 200507841 A TW200507841 A TW 200507841A TW 093108034 A TW093108034 A TW 093108034A TW 93108034 A TW93108034 A TW 93108034A TW 200507841 A TW200507841 A TW 200507841A
- Authority
- TW
- Taiwan
- Prior art keywords
- antibacterial agents
- quinoline
- mammals
- treatment
- bacterial infections
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 150000005054 naphthyridines Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45814703P | 2003-03-27 | 2003-03-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200507841A true TW200507841A (en) | 2005-03-01 |
Family
ID=33131758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW093108034A TW200507841A (en) | 2003-03-27 | 2004-03-25 | Antibacterial agents |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060189601A1 (zh) |
| EP (1) | EP1605938B1 (zh) |
| JP (1) | JP2006521401A (zh) |
| AR (1) | AR043938A1 (zh) |
| AT (1) | ATE422495T1 (zh) |
| DE (1) | DE602004019399D1 (zh) |
| ES (1) | ES2321618T3 (zh) |
| TW (1) | TW200507841A (zh) |
| WO (1) | WO2004087145A2 (zh) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200406413A (en) | 2002-06-26 | 2004-05-01 | Glaxo Group Ltd | Compounds |
| AR040336A1 (es) | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto |
| ES2340484T3 (es) | 2002-11-05 | 2010-06-04 | Glaxo Group Limited | Agentes antibacterianos. |
| EP1560488B1 (en) | 2002-11-05 | 2010-09-01 | Glaxo Group Limited | Antibacterial agents |
| WO2004050036A2 (en) * | 2002-12-04 | 2004-06-17 | Glaxo Group Limited | Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
| US7160888B2 (en) * | 2003-08-22 | 2007-01-09 | Warner Lambert Company Llc | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
| US7691850B2 (en) | 2004-06-15 | 2010-04-06 | Glaxo Group Limited | Antibacterial agents |
| JP2008505920A (ja) * | 2004-07-08 | 2008-02-28 | グラクソ グループ リミテッド | 抗菌剤 |
| ATE484509T1 (de) | 2004-08-02 | 2010-10-15 | Glaxo Group Ltd | Antibakterielle mittel |
| WO2006081289A2 (en) * | 2005-01-25 | 2006-08-03 | Glaxo Group Limited | Antibacterial agents |
| WO2006081179A1 (en) | 2005-01-25 | 2006-08-03 | Glaxo Group Limited | Antibacterial agents |
| WO2006081264A1 (en) * | 2005-01-25 | 2006-08-03 | Glaxo Group Limited | Antibacterial agents |
| US7592334B2 (en) * | 2005-01-25 | 2009-09-22 | Glaxo Group Limited | Antibacterial agents |
| EP1863483A4 (en) | 2005-03-31 | 2010-03-31 | Janssen Pharmaceutica Nv | Bicyclic pyrazole compounds as anti-bacteriostatic agents |
| MY150958A (en) | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
| JPWO2007099828A1 (ja) * | 2006-02-23 | 2009-07-16 | 塩野義製薬株式会社 | 環式基で置換された含窒素複素環誘導体 |
| EP2007377A4 (en) | 2006-04-06 | 2011-08-17 | Glaxo Group Ltd | ANTIBACTERIAL ACTIVE SUBSTANCES |
| DE602007009205D1 (de) | 2006-04-06 | 2010-10-28 | Glaxo Group Ltd | Pyrrolochinoxalinonderivate als antibakterielle mittel |
| EP1992628A1 (en) | 2007-05-18 | 2008-11-19 | Glaxo Group Limited | Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones |
| WO2008128942A1 (en) * | 2007-04-20 | 2008-10-30 | Glaxo Group Limited | Tricyclic nitrogen containing compounds as antibacterial agents |
| WO2009034546A2 (en) * | 2007-09-13 | 2009-03-19 | Actelion Pharmaceuticals Ltd | Trans-decahydroisoquinoline derivatives |
| EP2080761A1 (en) | 2008-01-18 | 2009-07-22 | Glaxo Group Limited | Compounds |
| JP2012505866A (ja) | 2008-10-17 | 2012-03-08 | グラクソ グループ リミテッド | 抗菌剤として使用される三環式窒素化合物 |
| CA2751892A1 (en) | 2009-01-15 | 2010-07-22 | Rutgers, The State University Of New Jersey | Benzo [c] phenanthridines as antimicrobial agents |
| JP5653935B2 (ja) | 2009-01-15 | 2015-01-14 | グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ | 抗菌薬として有用なナフチリジン―２（１ｈ）−オン化合物 |
| US20120059026A1 (en) | 2009-04-30 | 2012-03-08 | University Of Medicine And Dentistry Of New Jersey | Antimicrobial agents |
| WO2011156626A1 (en) | 2010-06-09 | 2011-12-15 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| US9102617B2 (en) | 2010-06-25 | 2015-08-11 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| WO2013106756A2 (en) * | 2012-01-13 | 2013-07-18 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| WO2013142712A1 (en) | 2012-03-21 | 2013-09-26 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| AR096135A1 (es) | 2013-05-02 | 2015-12-09 | Actelion Pharmaceuticals Ltd | Derivados de la quinolona |
| US9458150B2 (en) | 2013-11-08 | 2016-10-04 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| AR101674A1 (es) | 2014-08-22 | 2017-01-04 | Glaxosmithkline Ip Dev Ltd | Uso de un compuesto tricíclico que contiene nitrógeno |
| MA41168A (fr) | 2014-12-17 | 2017-10-24 | Acraf | Nouveaux composés antibactériens |
| MA41169A (fr) * | 2014-12-17 | 2017-10-24 | Acraf | Composés antibactériens à large spectre d'activité |
| UY36851A (es) * | 2015-08-16 | 2017-03-31 | Glaxosmithkline Ip Dev Ltd | Compuestos para uso en aplicaciones antibacterianas |
| US10513528B2 (en) | 2016-02-25 | 2019-12-24 | Taxis Pharmaceuticals, Inc. | Synthetic processes and intermediates |
| WO2018183917A1 (en) | 2017-03-30 | 2018-10-04 | Taxis Pharmaceuticals, Inc. | Synthetic processes and synthetic intermediates |
| CN114793434A (zh) | 2019-10-18 | 2022-07-26 | 加利福尼亚大学董事会 | 作为用于治疗病原性血管病症的药剂的3-苯基磺酰基-喹啉衍生物 |
| EP4471015A1 (en) * | 2023-06-01 | 2024-12-04 | Centre National de la Recherche Scientifique | Process for the selective cleavage of c-scf3 bonds and analogues |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4425146A1 (de) * | 1994-07-15 | 1996-01-18 | Basf Ag | Verwendung heterocyclischer Verbindungen |
| US5578629A (en) * | 1995-03-29 | 1996-11-26 | Merck & Co., Inc. | Benzamide-containing inhibitors of farnesyl-protein transferase |
| US5534537A (en) * | 1995-03-29 | 1996-07-09 | Merck & Co., Inc. | Prodrugs of inhibitors of farnesyl-protein transferase |
| DE19600934A1 (de) * | 1996-01-12 | 1997-07-17 | Basf Ag | Substituierte Aza- und Diazacycloheptan- und Cyclooctanverbindungen und deren Verwendung |
| IT1293807B1 (it) * | 1997-08-01 | 1999-03-10 | Recordati Chem Pharm | Derivati 1- (n-fenilaminoalchil) piperazinici sostituiti alla posizione 2 dell'anello fenilico |
| AR019190A1 (es) * | 1998-07-08 | 2001-12-26 | Sod Conseils Rech Applic | Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos |
| GB9906624D0 (en) * | 1999-03-23 | 1999-05-19 | Smithkline Beecham Plc | Novel compounds |
| WO2000078716A1 (en) * | 1999-06-24 | 2000-12-28 | Toray Industries, Inc. | α1B-ADRENERGIC RECEPTOR ANTAGONISTS |
| CZ290178B6 (cs) * | 1999-07-22 | 2002-06-12 | Sankyo Company Limited | Deriváty cyklobutenu |
| IL149177A0 (en) * | 1999-11-05 | 2002-11-10 | Sod Conseils Rech Applic | Novel heterocyclic compounds and their use as medicines |
| GB0031088D0 (en) * | 2000-12-20 | 2001-01-31 | Smithkline Beecham Plc | Medicaments |
| GB0101577D0 (en) * | 2001-01-22 | 2001-03-07 | Smithkline Beecham Plc | Compounds |
| FR2822154B1 (fr) * | 2001-03-13 | 2005-10-21 | Aventis Pharma Sa | Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent |
| US7494901B2 (en) * | 2002-04-05 | 2009-02-24 | Microng Technology, Inc. | Methods of forming semiconductor-on-insulator constructions |
-
2004
- 2004-03-25 TW TW093108034A patent/TW200507841A/zh unknown
- 2004-03-26 EP EP04758428A patent/EP1605938B1/en not_active Expired - Lifetime
- 2004-03-26 ES ES04758428T patent/ES2321618T3/es not_active Expired - Lifetime
- 2004-03-26 JP JP2006509364A patent/JP2006521401A/ja active Pending
- 2004-03-26 US US10/550,676 patent/US20060189601A1/en not_active Abandoned
- 2004-03-26 AT AT04758428T patent/ATE422495T1/de not_active IP Right Cessation
- 2004-03-26 WO PCT/US2004/009371 patent/WO2004087145A2/en not_active Ceased
- 2004-03-26 DE DE602004019399T patent/DE602004019399D1/de not_active Expired - Lifetime
- 2004-03-26 AR ARP040101019A patent/AR043938A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006521401A (ja) | 2006-09-21 |
| ES2321618T3 (es) | 2009-06-09 |
| DE602004019399D1 (de) | 2009-03-26 |
| US20060189601A1 (en) | 2006-08-24 |
| WO2004087145A3 (en) | 2004-11-04 |
| EP1605938A4 (en) | 2006-11-22 |
| AR043938A1 (es) | 2005-08-17 |
| EP1605938A2 (en) | 2005-12-21 |
| EP1605938B1 (en) | 2009-02-11 |
| WO2004087145A2 (en) | 2004-10-14 |
| ATE422495T1 (de) | 2009-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200507841A (en) | Antibacterial agents | |
| AU2003291227A8 (en) | Antibacterial agents | |
| WO2004058144A3 (en) | Antibacterial agents | |
| AU2003303956A8 (en) | Antibacterial agents | |
| WO2006002047A3 (en) | Antibacterial agents | |
| AU2002328972A1 (en) | Piperidine derivatives as antibacterial agents | |
| AU6339599A (en) | Quinoline derivatives and their use as antibacterial agents | |
| MY138285A (en) | Fab i inhibitors | |
| GB0101577D0 (en) | Compounds | |
| AU2003251474A8 (en) | Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity | |
| BR0210016A (pt) | Heterociclos bicìclicos contendo nitrogênio, para uso como antibacterianos | |
| MXPA03000708A (es) | Aminopiperidin quinolinas y sus analogos azaisostericos con actividad antibacteriana. | |
| ATE327231T1 (de) | Chinolinderivate als antibakterielle mittel | |
| WO2007118130A3 (en) | Antibacterial agents | |
| WO2006081289A3 (en) | Antibacterial agents | |
| WO2006020561A3 (en) | Antibacterial agents | |
| NO20052362D0 (no) | Fremgangsmater for administrering av dalbavancin for behandling av bakterielle infeksjoner | |
| WO2007016610A3 (en) | Antibacterial agents | |
| AU2003294565A8 (en) | Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents | |
| EP1781669A4 (en) | ANTIBACTERIAL AGENTS | |
| WO2006010040A3 (en) | Antibacterial agents | |
| WO2006081182A3 (en) | Antibacterial agents | |
| WO2006081178A3 (en) | Antibacterial agents | |
| WO2005118613A3 (de) | Antibakterielle amid-makrozyklen |